Changes in ectopic lipids, insulin sensitivity, and beta cell function after a low-fat vegan diet in adults with type 2 diabetes: a 16-week single-arm clinical trial.
Hana Kahleova, Kitt Petersen, Gerald I Shulman et al.
✦ AI-curated · Sources linked
In 30 seconds
This 16-week, single-arm clinical trial examined changes in ectopic lipids, insulin sensitivity, advanced glycation end products, and beta-cell function in 25 adults with type 2 diabetes following an ad libitum low-fat vegan diet. Mean body weight fell by 6.0 kg (95% CI -7.0 to -5.1; p<0.001), alongside a 33.0% reduction in hepatocellular lipids (95% CI -48.7 to -17.3; p<0.001). Measures of insulin sensitivity and several markers of beta-cell function also improved. The findings describe changes during the intervention but do not establish that the diet caused them.
Key findings
- Mean body weight decreased by 6.0 kg (95% CI -7.0 to -5.1; p<0.001), with fat mass accounting for most of the reduction.
- Hepatocellular lipids decreased by 33.0% (95% CI -48.7 to -17.3; p<0.001); visceral fat volume also fell by 290 cm 3 (95% CI -467 to -114; p=0.003).
- HOMA-IR fell by -2.5 (95% CI -4.1 to -0.9; p=0.004), while PREDIM increased by +1.3 mg/min/kg (95% CI +0.6 to +2.1; p=0.002).
- The AGE score decreased by 0.4 (95% CI -0.6 to -0.2; p=0.002), and several measured beta-cell function markers increased.
Why it matters
Ectopic fat, insulin resistance, and beta-cell function are relevant to metabolic health in type 2 diabetes. The observed concurrent changes suggest that a low-fat vegan dietary intervention can be accompanied by improvements across these measures, not only body weight. These results may inform discussion of dietary approaches, while the study design limits conclusions about whether the diet itself produced the changes.
What to keep in mind
The trial was single-arm, with no comparator group, and included 25 participants followed for 16 weeks; changes cannot be attributed to the diet with the certainty of a controlled comparison.